# Autonation, Inc.: financial statements, quarterly

AN · NYSE · CIK 350698 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/an.md) · [Financials](/companies/an/financials.md) · [Filings](/companies/an/filings.md) · [Insiders](/companies/an/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/an/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,893](/filings/0000350698-24-000111.md) | [6,767 d](/filings/0001628280-26-007800.md) | [6,486](/filings/0000350698-25-000085.md) | [6,480](/filings/0000350698-25-000100.md) | [6,586](/filings/0001628280-25-046121.md) | [7,213 d](/filings/0001628280-26-007800.md) | [6,690](/filings/0001628280-26-029317.md) | [6,974](/filings/0001628280-26-051427.md) | [7,037](/filings/0001628280-25-046121.md) | [6,929 d](/filings/0001628280-26-007800.md) | [6,552](/filings/0001628280-26-029317.md) | [6,930](/filings/0001628280-26-051427.md) |
| Cost of revenue | $m | [5,598](/filings/0000350698-24-000111.md) | [5,552 d](/filings/0001628280-26-007800.md) | [5,288](/filings/0000350698-25-000085.md) | [5,317](/filings/0000350698-25-000100.md) | [5,403](/filings/0001628280-25-046121.md) | [5,972 d](/filings/0001628280-26-007800.md) | [5,471](/filings/0001628280-26-029317.md) | [5,699](/filings/0001628280-26-051427.md) | [5,799](/filings/0001628280-25-046121.md) | [5,714 d](/filings/0001628280-26-007800.md) | [5,341](/filings/0001628280-26-029317.md) | [5,699](/filings/0001628280-26-051427.md) |
| Gross profit | $m | [1,295](/filings/0000350698-24-000111.md) | [1,215 d](/filings/0001628280-26-007800.md) | [1,198](/filings/0000350698-25-000085.md) | [1,163](/filings/0000350698-25-000100.md) | [1,183](/filings/0001628280-25-046121.md) | [1,242 d](/filings/0001628280-26-007800.md) | [1,220](/filings/0001628280-26-029317.md) | [1,275](/filings/0001628280-26-051427.md) | [1,238](/filings/0001628280-25-046121.md) | [1,215 d](/filings/0001628280-26-007800.md) | [1,211](/filings/0001628280-26-029317.md) | [1,231](/filings/0001628280-26-051427.md) |
| Selling, general and administrative | $m | [819](/filings/0000350698-24-000111.md) | [808 d](/filings/0001628280-26-007800.md) | [793](/filings/0000350698-25-000085.md) | [826](/filings/0000350698-25-000100.md) | [811](/filings/0001628280-25-046121.md) | [834 d](/filings/0001628280-26-007800.md) | [822](/filings/0001628280-26-029317.md) | [855](/filings/0001628280-26-051427.md) | [850](/filings/0001628280-25-046121.md) | [836 d](/filings/0001628280-26-007800.md) | [842](/filings/0001628280-26-029317.md) | [856](/filings/0001628280-26-051427.md) |
| Operating income | $m | [420](/filings/0000350698-24-000111.md) | [350 d](/filings/0001628280-26-007800.md) | [340](/filings/0000350698-25-000085.md) | [275](/filings/0000350698-25-000100.md) | [351](/filings/0001628280-25-046121.md) | [340 d](/filings/0001628280-26-007800.md) | [336](/filings/0001628280-26-029317.md) | [218](/filings/0001628280-26-051427.md) | [372](/filings/0001628280-25-046121.md) | [314 d](/filings/0001628280-26-007800.md) | [314](/filings/0001628280-26-029317.md) | [319](/filings/0001628280-26-051427.md) |
| Income tax | $m | [83.7](/filings/0000350698-24-000111.md) | [61.5 d](/filings/0001628280-26-007800.md) | [63.2](/filings/0000350698-25-000085.md) | [44.0](/filings/0000350698-25-000100.md) | [61.6](/filings/0001628280-25-046121.md) | [55.7 d](/filings/0001628280-26-007800.md) | [58.5](/filings/0001628280-26-029317.md) | [52.0](/filings/0001628280-26-051427.md) | [72.5](/filings/0001628280-25-046121.md) | [52.4 d](/filings/0001628280-26-007800.md) | [70.3](/filings/0001628280-26-029317.md) | [61.7](/filings/0001628280-26-051427.md) |
| Net income | $m | [244](/filings/0000350698-24-000111.md) | [216 d](/filings/0001628280-26-007800.md) | [190](/filings/0001628280-25-046121.md) | [130](/filings/0001628280-25-046121.md) | [186](/filings/0001628280-25-046121.md) | [186 d](/filings/0001628280-26-007800.md) | [176](/filings/0001628280-26-051427.md) | [86.4](/filings/0001628280-26-051427.md) | [215](/filings/0001628280-25-046121.md) | [172 d](/filings/0001628280-26-007800.md) | [205](/filings/0001628280-26-051427.md) | [182](/filings/0001628280-26-051427.md) |
| Diluted EPS | $ per share | [5.54](/filings/0000350698-24-000111.md) | not reported | [4.49](/filings/0000350698-25-000085.md) | [3.20](/filings/0000350698-25-000100.md) | [4.61](/filings/0001628280-25-046121.md) | not reported | [4.45](/filings/0001628280-26-029317.md) | [2.26](/filings/0001628280-26-051427.md) | [5.65](/filings/0001628280-25-046121.md) | not reported | [5.85](/filings/0001628280-26-029317.md) | [5.39](/filings/0001628280-26-051427.md) |
| Basic EPS | $ per share | [5.59](/filings/0000350698-24-000111.md) | not reported | [4.53](/filings/0000350698-25-000085.md) | [3.22](/filings/0000350698-25-000100.md) | [4.66](/filings/0001628280-25-046121.md) | not reported | [4.50](/filings/0001628280-26-029317.md) | [2.29](/filings/0001628280-26-051427.md) | [5.72](/filings/0001628280-25-046121.md) | not reported | [5.92](/filings/0001628280-26-029317.md) | [5.44](/filings/0001628280-26-051427.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000350698-23-000143.md) | [0.1](/filings/0000350698-25-000029.md) | [0.1](/filings/0000350698-24-000074.md) | [0.1](/filings/0000350698-24-000098.md) | [0.1](/filings/0000350698-24-000111.md) | [0.1](/filings/0001628280-26-007800.md) | [0.1](/filings/0000350698-25-000085.md) | [0.1](/filings/0000350698-25-000100.md) | [0.1](/filings/0001628280-25-046121.md) | [0.1](/filings/0001628280-26-051427.md) | [0.1](/filings/0001628280-26-029317.md) | [0.1](/filings/0001628280-26-051427.md) |
| Current assets | $bn | [3.8](/filings/0000350698-23-000143.md) | [4.3](/filings/0000350698-25-000029.md) | [4.2](/filings/0000350698-24-000074.md) | [4.9](/filings/0000350698-24-000098.md) | [4.7](/filings/0000350698-24-000111.md) | [4.7](/filings/0001628280-26-007800.md) | [4.5](/filings/0000350698-25-000085.md) | [4.6](/filings/0000350698-25-000100.md) | [4.7](/filings/0001628280-25-046121.md) | [4.6](/filings/0001628280-26-051427.md) | [4.6](/filings/0001628280-26-029317.md) | [4.8](/filings/0001628280-26-051427.md) |
| Total assets | $bn | [11.2](/filings/0000350698-23-000143.md) | [12.0](/filings/0001628280-26-007800.md) | [12.0](/filings/0000350698-24-000074.md) | [12.8](/filings/0000350698-24-000098.md) | [12.9](/filings/0000350698-24-000111.md) | [13.0](/filings/0001628280-26-007800.md) | [13.3](/filings/0000350698-25-000085.md) | [13.6](/filings/0000350698-25-000100.md) | [14.2](/filings/0001628280-25-046121.md) | [14.4](/filings/0001628280-26-051427.md) | [14.6](/filings/0001628280-26-029317.md) | [15.5](/filings/0001628280-26-051427.md) |
| Current liabilities | $bn | [4.5](/filings/0000350698-23-000143.md) | [5.6](/filings/0000350698-25-000029.md) | [5.4](/filings/0000350698-24-000074.md) | [6.2](/filings/0000350698-24-000098.md) | [6.0](/filings/0000350698-24-000111.md) | [6.3](/filings/0001628280-26-007800.md) | [5.9](/filings/0000350698-25-000085.md) | [5.7](/filings/0000350698-25-000100.md) | [5.9](/filings/0001628280-25-046121.md) | [5.5](/filings/0001628280-26-051427.md) | [5.6](/filings/0001628280-26-029317.md) | [6.2](/filings/0001628280-26-051427.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.4](/filings/0000350698-23-000143.md) | [0.4](/filings/0000350698-25-000029.md) | [0.3](/filings/0000350698-24-000074.md) | [0.4](/filings/0000350698-24-000098.md) | [0.4](/filings/0000350698-24-000111.md) | [0.6](/filings/0001628280-26-007800.md) | [0.3](/filings/0000350698-25-000085.md) | [0.1](/filings/0000350698-25-000100.md) | [0.2](/filings/0001628280-25-046121.md) | [0.2](/filings/0001628280-26-051427.md) | [0.3](/filings/0001628280-26-029317.md) | [0.6](/filings/0001628280-26-051427.md) |
| Shareholders' equity | $bn | [2.1](/filings/0000350698-24-000111.md) | [2.2](/filings/0001628280-26-007800.md) | [2.4](/filings/0001628280-25-046121.md) | [2.2](/filings/0001628280-25-046121.md) | [2.4](/filings/0001628280-25-046121.md) | [2.5](/filings/0001628280-26-051427.md) | [2.4](/filings/0001628280-26-051427.md) | [2.5](/filings/0001628280-26-051427.md) | [2.5](/filings/0001628280-25-046121.md) | [2.3](/filings/0001628280-26-051427.md) | [2.2](/filings/0001628280-26-051427.md) | [2.3](/filings/0001628280-26-051427.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [256 d](/filings/0000350698-24-000111.md) | [(38.6) d](/filings/0001628280-26-007800.md) | [295](/filings/0000350698-25-000085.md) | [(59.6) d](/filings/0000350698-25-000100.md) | [(70.0) d](/filings/0001628280-25-046121.md) | [150 d](/filings/0001628280-26-007800.md) | [(52.5)](/filings/0001628280-26-029317.md) | [(178) d](/filings/0001628280-26-051427.md) | [192 d](/filings/0001628280-25-046121.md) | [151 d](/filings/0001628280-26-007800.md) | [22.2](/filings/0001628280-26-029317.md) | [(71.1) d](/filings/0001628280-26-051427.md) |
| Capital expenditure | $m | [87.0 d](/filings/0000350698-24-000111.md) | [124 d](/filings/0001628280-26-007800.md) | [93.7](/filings/0000350698-25-000085.md) | [87.5 d](/filings/0000350698-25-000100.md) | [81.0 d](/filings/0001628280-25-046121.md) | [66.3 d](/filings/0001628280-26-007800.md) | [75.2](/filings/0001628280-26-029317.md) | [79.0 d](/filings/0001628280-26-051427.md) | [68.9 d](/filings/0001628280-25-046121.md) | [86.3 d](/filings/0001628280-26-007800.md) | [56.4](/filings/0001628280-26-029317.md) | [69.6 d](/filings/0001628280-26-051427.md) |
| Share repurchases | $m | [200 d](/filings/0000350698-24-000111.md) | [151 d](/filings/0001628280-26-007800.md) | [38.7](/filings/0000350698-25-000085.md) | [311 d](/filings/0000350698-25-000100.md) | [5.6 d](/filings/0001628280-25-046121.md) | [104 d](/filings/0001628280-26-007800.md) | [221](/filings/0001628280-26-029317.md) | [33.2 d](/filings/0001628280-26-051427.md) | [176 d](/filings/0001628280-25-046121.md) | [362 d](/filings/0001628280-26-007800.md) | [301](/filings/0001628280-26-029317.md) | [169 d](/filings/0001628280-26-051427.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.9](/filings/0000350698-23-000143.md) | [47.6](/filings/0000350698-24-000074.md) | [45.3](/filings/0000350698-24-000098.md) | [44.0](/filings/0000350698-24-000111.md) | [42.3](/filings/0000350698-25-000085.md) | [40.7](/filings/0000350698-25-000100.md) | [40.3](/filings/0001628280-25-046121.md) | [39.4](/filings/0001628280-26-029317.md) | [38.3](/filings/0001628280-26-051427.md) | [38.1](/filings/0001628280-25-046121.md) | [35.1](/filings/0001628280-26-029317.md) | [33.8](/filings/0001628280-26-051427.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,060,806 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051427.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.